Guaifenesin

DB00874ApprovedInvestigationalVet approvedSmall moleculeExpectorants

Guaifenesin is an expectorant commonly found in OTC products for the symptomatic relief from congested chests and coughs associated with cold, bronchitis, and/or other breathing illnesses. Guaifenesin possesses a storied history, having been originally formally approved by the US FDA in 1952 and continues to be one of very few - if not perhaps the only drug that is readily available...

Chemical structure of Guaifenesin
Mechanism
Curator reviewed · 4 references
Primary indication
Guaifenesin is an expectorant that is indicated for providing temporary symptomatic relief from congested chests and coughs which may be due to a cold, bronchitis, and/or other breathing illnesses.Curator reviewed · 80 structured indications
Formula / weight
C10H14O4 · 198.2158 g/mol (avg)
First approval
Canada, 1996 · United States, 2003
Also known as
Glyceryl guaiacolate · guaiphenesin
Brand names
  • Broncotron
  • Bronkaid
  • Cheracol D
  • Cheratussin
  • Cheratussin Dac
  • Codar Gf
  • Coricidin Hbp Chest Congestion
  • DM
  • Deconex
  • Delsym Cough Plus Chest Congestion DM
  • Despec Reformulated Jun 2008
  • Diabetic Tussin DM
  • Diabetic Tussin EX
  • Diphen
  • Entex Lq
  • Entex T
  • G-zyncof
  • Gilphex
  • M-clear Wc
  • Mar-cof Cg
  • Mucinex
  • Mucinex Children's Cough
  • Mucinex Cough
  • Mucinex D
  • Mucinex DM
  • Ninjacof Xg
  • Obredon
  • Pediacare Children's Cough and Congestion
  • Refenesen
  • Refenesen PE
  • Rescon-GG
  • Robafen
  • Robafen DM
  • Robitussin Chest Congestion
  • Robitussin Cough & Congestion
  • Robitussin Maximum Strength Cough Plus Chest Congestion DM
  • Safetussin DM
  • Scot-tussin
  • Scot-tussin DM
  • Siltussin
  • Tusnel C
  • Tusnel Diabetic
  • +32 moreShow less

Resolves to

Structure
InChIKeyHSRJKNPTNIJEKV-UHFFFAOYSA-NSMILESCOC1=CC=CC=C1OCC(O)CO

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
35Clinical trialsPhase, status and sponsor resolved per trial
Sign in
80Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
4,733Marketed productsAcross 10 countries and 800 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Guaifenesin, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account